Medexus Pharmaceuticals Inc T.MDP

Alternate Symbol(s): MEDXF

Healthcare

Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its lead products are IXINITY (US), Rupall (Canada), Rasuvo (US) and Metoject (Canada), and Gleolan (US). IXINITY (US) is an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B. Rupall (Canada) is a prescription allergy medication with a mode of action. Rasuvo (US) and Metoject (Canada) is a formulation of methotrexate designed to treat rheumatoid arthritis and other autoimmune diseases. Gleolan (US) is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.

TSX:MDP - Post by User

Medexus Pharmaceuticals Inc > If interested in short postion for MDP

<< Previous

Bullboard Posts

Next >>

Comment by Rockafellowon May 05, 2021 1:08pm

111 Views

Post# 33132902

RE:RE:RE:If interested in short postion for MDP

While urul researching this out u better get over to IVS & find out what desjardine is up to & why no trading ... Ur pal is spraying again over there. ...
... Over there, over there,...
I will c u over there ..

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1